Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Skin Phototype and Disease: A Comprehensive Genetic Approach to Pigmentary Traits Pleiotropy Using PRS in the GCAT Cohort. | Genes (Basel) | 2023 | 36672889 | PubTator, text mining | PubMed |
| Diagnostic Yield of Genetic Testing for Ocular and Oculocutaneous Albinism in a Diverse United States Pediatric Population. | Genes (Basel) | 2023 | 36672876 | PubTator, text mining | PubMed |
| Chemical- and Drug-Induced Allergic, Inflammatory, and Autoimmune Diseases Via Haptenation. | Biology (Basel) | 2023 | 36671815 | PubTator, text mining | PubMed |
| Vitiligo and Mental Health: Natural Compounds' Usefulness. | Antioxidants (Basel) | 2023 | 36671038 | PubTator, text mining | PubMed |
Single-cell RNA sequencing reveals transcriptional changes of human choroidal and retinal pigment epithelium cells during fetal development, in healthy adult and intermediate age-related macular degeneration. | Hum Mol Genet | 2023 | 36645183 | PubTator, text mining | PubMed |
| The CNC-family transcription factor Nrf3 coordinates the melanogenesis cascade through macropinocytosis and autophagy regulation. | Cell Rep | 2023 | 36640303 | PubTator, text mining | PubMed |
| S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas. | Neoplasia | 2023 | 36638586 | PubTator, text mining | PubMed |
| Anti-LGI4 Antibody Is a Novel Juxtaparanodal Autoantibody for Chronic Inflammatory Demyelinating Polyneuropathy. | Neurol Neuroimmunol Neuroinflamm | 2023 | 36631269 | PubTator, text mining | PubMed |
| The genetic basis of plumage coloration and elevation adaptation in a clade of recently diverged alpine and arctic songbirds. | Evolution | 2023 | 36626815 | PubTator, text mining | PubMed |
| Melatonin reduces melanogenesis by inhibiting the paracrine effects of keratinocytes. | Exp Dermatol | 2023 | 36620869 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Scombroid Food Poisoning. | Int J Mol Sci | 2023 | 36614252 | PubTator, text mining | PubMed |
| Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma. | Int J Mol Sci | 2023 | 36614248 | PubTator, text mining | PubMed |
| Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report. | BMC Med Genomics | 2023 | 36604730 | PubTator, text mining | PubMed |
| Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy. | J Immunother Cancer | 2023 | 36593066 | PubTator, text mining | PubMed |
| Review on potential effects of traditional Chinese medicine on glaucoma. | J Ethnopharmacol | 2023 | 36567037 | PubTator, text mining | PubMed |
| Genetic architecture and evolution of color variation in American black bears. | Curr Biol | 2023 | 36528024 | PubTator, text mining | PubMed |
| Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients. | J Cancer Res Clin Oncol | 2023 | 36527482 | PubTator, text mining | PubMed |
| Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model. | Pigment Cell Melanoma Res | 2023 | 36478412 | PubTator, text mining | PubMed |
| Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics. | Bioact Mater | 2023 | 36471724 | PubTator, text mining | PubMed |
| In vitro characterization of the intramelanosomal domain of human recombinant TYRP1 and its oculocutaneous albinism type 3-related mutant variants. | Protein Sci | 2023 | 36412553 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=21